Hormonal Treatment and Depression

Past research has demonstrated a link between traditional prostate cancer hormone therapy (HT) and the risk of depression among prostate cancer patients.

A retrospective clinical trial investigated whether second-generation antiandrogens (AAs) are also associated with increased risk of depression.

Three treatments were compared during the study: no HT, traditional HT, and second-generation AA.

Results indicate that patients receiving a second-generation AA had an increased risk of depression compared with traditional HT alone or no HT.

These findings emphasize the need for emotional distress monitoring and the implantation of focused interventions to alleviate symptoms among these patients.

For more info:

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787430.

This content is provided for your general education and information only. It does not necessarily reflect Belong’s views and opinions. Belong does not endorse or support any specific product, service or treatment.

More Articles

Meet Dave and Fred – Belong’s AI Health Mentors

Whether you’re looking for support with health conditions or weight loss and maintenance, Belong AI…

Methylene Blue and Cancer

Methylene blue, a centuries-old medicine dye, has recently gained interest for its potential role in…

When Allergies Meet MS: How to Stay One Step Ahead

From sneezing fits to itchy eyes and fatigue, allergies can add an unexpected layer of challenge. But…

Targeted Therapy: A Personalized Approach to Cancer Treatment

Targeted therapy is a modern cancer treatment designed to attack cancer cells with precision while…

Finding Your Voice: How MS Can Affect Your Vocal Cords

One that many people don’t expect is how MS can impact their voice. If you’ve…

The Importance of a Second Opinion After a Cancer Diagnosis

Sometimes, seeking a second opinion can help ensure you have the right information and treatment…
Skip to content